July 1, 2014 — In the wake of a deadly fungal meningitis outbreak, the U.S. Food and Drug Administration (FDA) has proposed a new set of regulations for good manufacturing practices at compounding pharmacies.
The documents include draft guidance for Current Good Manufacturing Practices (CGMP) aimed at ensuring sterility and improving the general safety of compounded medicines.
The FDA issued a proposed rule that would update its list of risky drugs that have been removed from the market or are banned over safety concerns. The agency wants to add 25 new drugs to a list of pharmaceutical ingredients that cannot be compounded. The FDA also wants to re-open the nomination process for new pharmaceutical ingredients that can be compounded.
For pharmacies who violate these rules, the FDA issued final guidance for a non-exhaustive list of enforcement actions.
Meanwhile, lawmakers in Massachusetts have passed a bill expanding regulation of compounding pharmacies in the state. The bill reorganizes the state pharmacy board, creates specialty licenses for different types of compounding pharmacies, and imposes a $25,000 fine for each safety violation, according to CBS News.
Oversight of the compounding industry has increased substantially in the last two years. In 2012, an outbreak of fungal meningitis was linked to one pharmacy in Massachusetts. Over 700 people in 20 states were infected, including 64 who died.
Do I have a Compounding Pharmacy Lawsuit?
The Schmidt Firm, PLLC is currently accepting compounding pharmacy induced injury cases in all 50 states. If you or somebody you know has been injured by a contaminated medicine, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.